Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus intravenous lidocaine for prevention of fentanyl-induced cough during anesthesia induction
IRCT20220102053599N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac, lidocaine and fentanyl in cough (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Cough incidence, Cough intensity and 4 more. Started Apr 2022; status: completed.
02
Drugs
ketorolaclidocainefentanyl
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20220102053599N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220102053599N1.